Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

A new innovation in cardiac surgery. A patient suffering from an arrhythmia—which could not be treated with standard techniques—became the first case in Canada to benefit from a cutting-edge surgical ...

Adagio Medical Holdings Inc. (NASDAQ:ADGM) said it has received Investigational Device Exemption (IDE) authorization from the ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation with a heated saline needle catheter was effective in eliminating clinical ventricular ...

Johns Hopkins researchers built a virtual replica of each patient’s heart, simulated the electrical circuits causing a ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an ...

We demonstrated a significant rise in CRP at a median of 49 days after AF ablation. Although the subsequent decline in CRP observed at second follow-up (a median of 179 days after ablation) was not ...

We report the case of a 56-year-old man who had sudden palpitations, lightheadedness, chest pain, and dyspnea. Paramedics arrived within about 10 minutes after the onset of symptoms and found that the ...